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INTRODUCTION
INTRODUCTION
         Cerebral venous sinus thrombosis (CVT) has been recognized since
the early part of the nineteenth century but still remains a diagnostic and
therapeutic challenge for the clinician given the varying and often
misleading clinical presentation of this condition. It forms a distinct
subgroup of cerebrovascular disease and is one of the commonest causes
of stroke in India.
Though earlier studies have reported higher mortality, recent
studies have reported lesser mortality due to earlier diagnosis, increased
awareness and management. Cross et al.1 noted “usually recovery is rapid
and complete, if the patient survives acute episode”. Three fourth of cases
of cerebral thrombosis in pregnancy and puerperium reported by him,
survived with good recovery. Although it may present with a variety of
signs and symptoms, headache is the most frequent and often the earliest
manifestation2.
          The diagnosis of cerebral venous sinus thrombosis requires high
index of suspicion. CT brain may show direct or indirect signs of cerebral
venous thrombosis. It may be normal in 10% of patients3. In such cases
advanced neurological diagnostic like magnetic resonance imaging with
venography is necessary to confirm cerebral venous thrombosis, but it is
not always readily available in many hospitals. It has been found that
early diagnosis of cerebral venous thrombosis is essential because early
treatment may prevent morbidity and may even be life saving. Cerebral
sinus venous thrombosis is considered to be a medical emergency, 4 mode
of onset highly variable, and spectrum of its clinical manifestations is
extremely wide.
          Management of CVT with anticoagulants especially heparin was a
controversy in earlier studies, but recent studies have proved heparin to
be both effective and safe even with hemorrhagic infarcts. Heparin
administration is the standard treatment for CVT5. Although lysis of the
sinus thrombus does not occur with systemic anticoagulation, prevention
of new thrombus formation is essential.
The goal of heparin therapy is to halt clot proliferation and prevent
worsening of clinical symptoms6 (Bousser  & Russell,  1997;  chow et  al.,
2000). Heparin is generally continued until the patient stabilizes (Bousser
& Russell). However, intracranial hemorrhage is a significant potential
consequence of this therapy7, and the benefits of anticoagulation must be
carefully weighed against the risks.
         Long-term medical therapy for CVT patients includes systemic
anticoagulation with warfarin for an average of 6 months (cakmak et al.,
2003). Fortunately, the risk of CVT recurrence during subsequent
pregnancies is low (mehraein et al., 2003), and patients are not routinely
counseled against future pregnancies.
AIM AND
OBJECTIVE
AIM AND OBJECTIVE
I. To analyse the commonest clinical modes of presentation
II. To find out the possible etiology
III. To analyse the topography of involved venous sinuses in Magnetic
resonance venogram.
IV. To evaluate clinical outcome.
REVIEW OF
LITERATURE
REVIEW OF LITERATURE
Strokes resulting from cerebral venous thrombosis are common
and have a distinct clinical profile, usually affect young persons,
predominantly women and carry a significant mortality if not adequately
treated. The term “primary” or “idiopathic” cerebral venous thrombosis is
used when no specific etiological factor is evident. “Secondary”
sinovenous thrombosis results from a variety of causes that include
injury, infection, hematological disturbances, dehydration, etc. In India
CVT in the early puerperal period is very common, 10-12 times higher
than in the west.8,9,10
History
          Ribes11 first reported primary venous sinus thrombosis in 1825. He
described in a 45 year old male, the clinical and autopsy spectrum of
superior sagital thrombosis. In 1828, John Aberocombei12 of Scotland
described this entity in a   24-year old lady who died from this disease.
Autopsy showed ischemic and hemorrhagic infarcts with thrombosed and
sclerosed cortical veins. Kalbag and Woolf13, Purdon martin, Sir Charles
symmonds  and  others  gave  a  precise  clinical  description  of  CVT  after
1940.Several large series with confirmation of diagnosis by angiograms,
surgical exploration, autopsy and recently with CT and MRI studies have
been reported from the Indian subcontinent.8,9,13
EPIDEMIOLOGY
            The true incidence of CVT is unknown. Ehlers and Courville14
found only superior sagittal sinus thrombosis in a series of 12,500
autopsies. Towbin found CVT in 9% of 182 consecutive autopsies15.
However, with more recent studies of large clinical series, the true
incidence of CVT is probably considerably higher than that thought from
autopsy series. Exact figures however remain elusive. CVT constitutes 10
-15 % of stroke according to Indian studies.8, 9, 13 Especially in the young
and in pre-menopausal women. People of all age groups may be affected
but there is slight preponderance in young women because of specific
causes like oral contraceptives, pregnancy and puerperium.16
        Puerperal CVT has been reported to account for up to 15-20% of
young stroke.12 It  is  the  commonest  cause  of  stroke  in  young  women in
India. Fifty percent of strokes in Indian women are related to pregnancy
and  puerperium  and  95.5%  of  these  are  due  to  CVT8. Prevalence of
postpartum CVT in India is 4.5/1000/year 8,9 In Indian population,
multiparas are affected more than  primipara  in proportion of 4:112 in a
study  sample  of   230  cases  of  CVT  seen  over  a  period  of  8  years  at
National Institute of Mental health and neuro sciences (Nimhans),
bangalore, 200 cases were in the puerperal period. It has been estimated
that prevalence rates of CVT in developing countries are approximately
10 times more than in developed countries. Currently aseptic CVT has
replaced septic CVT as the commonest cause.
PROGNOSIS
CVT associated with pregnancy is reported to have a better
prognosis  than  CVT  arising  from  other  causes,  with  a  mortality  rate  of
approximately 10% (Van der stege et. Al., 1997).17 Researchers have
estimated all-cause CVT mortality as 10%-30% (baker et. Al., 2001;
chow et al., 2000). In a retrospective review of 170 peripartum patients
with CVT, Lanska and Kryscio  (2000) reported that more than 93% of
patients were discharged home, and there were no deaths in their series.
Although many CVT patients experience some persistent neurologic
deficits, most will return to their previous level of function.
Relevant venous anatomy
The cerebral venous system consists of
(1)  dural venous sinuses
(2)  cerebral veins
The cerebral veins that empty into dural sinuses, which then drain
into the two internal jugular veins.
The dural venous sinuses
The dural venous sinuses are valve less, transloculated venous
blood channels and  may be divided into a superior group related to the
vault  and  a  basal  group  found  at  the  skull  base.  The  sagittal,  transverse
and straight sinuses are the main components of the superior group. The
basal group comprises of cavernous, petrosal and sphenoparietal sinuses.
The dural sinuses most commonly thrombosed are the superior sagittal
sinus (SSS), lateral sinus and cavernous sinus.
           Superficial cortical veins drain into the superior sagittal sinus
against the blood flow in the sinus, thus causing turbulence in the blood
stream that is further aggravated by the presence of fibrous septa in the
inferior angle of sinus. This explains the greater prevalence of superior
sagittal sinus thrombosis Intercommunication between the  various
venous sinuses provide alternative routes by which blood from dural
sinuses may flow if normal drainage is blocked.
Superior sagittal sinus (SSS)
SSS lies in the anterior border of falx cerebri and runs from the
foramen caecum to the occipital protuberance, where it joins with straight
sinus lateral and torcular herophili. The SSS is triangular in cross section,
increases in size from before backwards. In the majority of individuals,
most of its flow is directed to the right transverse sinus with the straight
sinus draining to the left transverse sinus.Cortical veins enter
perpendicular to the SSS anteriorly but the angle becomes shallower more
posteriorly as the veins entering against the direction of flow. SSS and
other sinuses play a major role in CSF circulation because they contain
most of the arachnoid villi and granulations (pacchionian bodies) in
which much of the CSF absorption takes place.
2. Inferior sagittal sinus
Situated in the posterior 2/3 of  falx cerebri. It joins the great
cerebral vein to form the straight sinus that eventually ends in the left
transverse sinus.
3. Lateral sinuses (LS)
              The lateral sinuses extend from the torcular herophili to the
jugular bulbs and consist of the transverse and sigmoid portions. They
drain blood from the cerebellum, brain stem and posterior portion of
cerebral hemispheres.
Transverse sinus(TS): Begins at the confluence of sinus (torcula
heterophili) to pass laterally and forward in the margin of tentorium
cerebelli to the postero inferior angle of the parietal bone and passes
down as a sigmoid sinus. It receives blood from the superior petrosal
sinus, inferior cerebral veins, and inferior cerebellar veins.The right is
usually ‘dominant’ and larger than on the left, receiving almost the entire
output of the superior sagittal sinus. The sinus on one side can be poorly
developed or even absent.
Sigmoid sinus(SS):   It is the direct continuation of the transverse sinus
and  is ‘s’ shaped. It extends from the postero inferior angle of the
parietal bone to the posterior part of the jugular foramen where it
continues as the superior bulb of internal jugular vein. Its tributaries are
the mastoid veins, cerebellar veins, internal auditory vein.
Straight sinus(STS): The straight sinus lies at the junction of the falx
and the tentorium and the torcular herophilius where the straight,
transverse and SSS meet. Numerous LS anatomic variations may be
misinterpreted in sinus occlusions on angiography.
           In hacker’s study, transverse portions were not visualised on
ipsilateral carotid angiograms in 14% of cases on left side and 33% on
right side, whereas sigmoid portions, which may be directly injected via
cerebral veins, failed to fill in 4% of cases on left side and were always
demonstrated on right.
4. Cavernous sinus
         This sinus drains venous blood from the orbits through the
ophthalmic  veins  and  from anterior  part  of  the  base  of  the  brain  via  the
sphenoparietal sinus and middle cerebral veins. They empty into both
superior and inferior petrosal sinuses and ultimately into internal jugular
vein. Because of their situation, cavernous sinuses are often thrombosed
in relation to infections of face or sphenoid sinusitis. In contrast to other
sites, infection is the leading cause of cavernous sinus thrombosis18.
5. Petrosal and sphenoparietal sinuses
          The superior petrosal sinuses are situated at the junction of the
tentorium and the petrous bone. They drain to transverse sinuses. The
inferior petrosal sinuses lie between the clivus and petrous apex and run
medial to the superior sinus joining the jugular bulb. The sphenoparietal
sinus is a medial extension of the sylvian vein and courses around the
greater sphenoid wing.
FIG -1 SINUSES AT THE BASE OF THE SKULL
FIG-2 SAGITTAL SECTION OF THE SKULL, SHOWING
THE SINUSES OF THE DURA
The supra tentorial venous system:
Cerebral veins:
Three groups of veins that draw blood supply from the brain are:
          1 Superficial cerebral, 2. Deep cerebral and 3. Veins of post fossae.
1. Superficial cerebral veins
           Some of the cortical veins the frontal, parietal and occipital
superior cerebral veins drain the cortex, which ascends to the SSS
whereas others, mainly the middle cerebral veins drain into the cavernous
sinuses. Troland’s greater anastomotic vein connects the SSS to middle
cerebral veins, which are  further  connected to LS by the vein of labbe.
           The cortical veins present some peculiarities that are important to
know to understand some of the clinical features of CVT –They have thin
walls, no muscle fibres and no valves. These features allow for dilatation
and reversal of the direction of blood flow when sinuses into which they
drain are occluded. They are linked by numerous anastomoses, allowing
development of collateral circulation (angiographically visible as
corkscrew vessels). This probably explains the good prognosis of the
venous thrombosis.
2. Deep cerebral veins
          The internal cerebral and basal veins both join to form the great
vein of galen, which continues as straight sinus which drains blood from
the deep white matter of the Cerebral hemispheres and from basal
ganglia. In contrast to the superficial system, the deep system anatomy is
constant and is always visualized on angiography, so that thrombosis is
easily recognized.19 They are choroidal veins, terminal vein, and basal
vein of Rosenthal.
3. Veins of posterior fossa
There are three groups:
(i) Superior veins draining into the galenic system.
(ii) Anterior veins draining into petrosal sinuses and
(iii) Posterior veins draining into the torcular or neighbouring SS and LS.
They are variable in course and angiographic diagnosis of their
occlusion is extremely difficult.
Causes of CVT
          In the pre-antibiotic era, infection was commonly associated with
CVT. But now it has become less common, various causative factors
implicated are infectious, inflammatory diseases, neoplasm,. coagulation
abnormalities, pregnancy and endocrine conditions.3, 6, 20. Puerperium is
associated with a six fold increase in risk of venous thromboembolism.
Even in developed countries, despite extensive investigations, in 25%
cases, no cause is found.
Table 1: CAUSES OF CEREBRAL VENOUS THROMBOSIS
A. Septic dural sinus thrombosis
v Local septic trauma
v Intracranial infections: abscess, empyema and meningitis
v Others -Otitis ,Sinusitis,Tonsillitis ,Stomatitis
v Systemic bacterial (typhoid, TB, septicemia, endocarditis)
v Viral (measles virus, hepatitis viruses, herpes simplex virus, HIV,
cytomegalovirus)
v Parasitic (malaria, trichinosis)
v Fungal (aspergillosis)
B. Non-septic dural sinus thrombosis
v Hemodynamic states
o Dehydration
o Fever
o Cardiac failure
v Hematological disorders -polycythemia vera
o Secondary polycythaemia
o Disseminated intravascular coagulation
o Sickle cell anemia and trait
o Cryoglobulinemia
o Paroxysmal and nocturnal hemoglobinuria
o Thrombocytosis
o Severe anemia
o Antithrombin-III deficiency
o Protein C & S deficiency
v Hormonal dysfunction
o Oral contraceptive use
o Pregnancy and puerperium
o Androgens
v Trauma
o Penetrating and non-penetrating head injuries
v Surgery
o Cardiac pacemakers
o Jugular venous catheters
v Metabolic disorders
o Homocystinuria
o Osteopetrosis
o Diabetes mellitus
v Neoplasia
o Meningioma
o Metastasis (usually hematogenous)
v Inflammatory disorders
o Anti phospholipid antibody syndrome
o Behcet’s disease
o Sarcoidosis
o SLE
o Wegener’s granulomatosis
o Polyarteritis nodosa
o Inflammatory bowel disease
o Ulcerative colitis
o Chron’s disease
o Cogan syndrome
v Vascular disorders
o  Arterio-venous malformation
o Arterial occlusions
o Sturge weber syndrome
Pathogenesis of cerebral venous thrombosis
       Various theories have been advocated for the pathogenesis of the
cerebral venous thrombosis. The main factors incriminated are:
1. Infective theory
2. Embolism
3. Local endothelial damage
4. Hypercoagulability
1. Infective theory
         The septic thrombosis is one where a purulent infection occurs with
attendant Thrombophlebitis. The classic examples of such a condition are
cavernous sinus thrombosis following facial infection and lateral sinus
thrombosis following otitis media. In Daif a et al.21 studied 40 cases of
CVT, infection was the cause of CVT in 7% of cases, whereas it was the
cause in 16% and 17% of cases reported by Bousser et al6 ,Shell and
Rathe, 22 respectively.
2. Martin-Batson theory of embolic thrombosis
In understanding the pathogenesis of puerperal venous thrombosis,
the studies of Batson (1940) and extension of the results of that study by
Martin (1941) are milestones. Batson (1940) in experimental work on
monkey and human cadavers showed that pelvic veins anastomose with
cerebral plexus of veins, positive proof of functional conduit in live
patients has not been shown. Based on these data martin (1941) argued
that under circumstances of increased intra-abdominal pressure, the
thrombi from parturient mother could pass into intracranial sinuses via
the vertebral plexus. Once the thrombus reaches the sagittal sinus, where
blood flow is slow, it acts as a nidus for further thrombosis19.This theory
fails to explain
(i) The basic mechanism of puerperal thrombosis.
(ii) The fact that SSS is most frequently involved, although
vertebral plexus of veins communicates with the occipital and
petrosal sinuses and not SSS.
(iii) Delayed onset of symptoms.
3. Kendall’s theory of local damage
Patho physiologically, there are important differences between
arterial and venous thrombosis. CVT has been described as a continuing
process in which the balance of prothrombotic and thrombolytic
processes is disturbed, leading to progression of the venous thrombus in
time24.This slow growth of thrombus and the good collateralization of the
venous vessels probably explain the usually gradual onset of symptoms,
frequently over weeks and months. Sudden onset however has been
described.
          Kendall23 was among the first to suggest that etiology of puerperal
CVT. It might be found by considering those aspects of the disorder that
produce Virchow’s classic triad: 1) stasis of blood flow; 2) vascular
endothelial damage; and 3) a hypercoagulable state. If a careful search is
made, each of these conditions for the generation of thrombosis may exist
in the pregnant patient, in particular one who presents with toxemia or
dehydration.
4. Stasis
         Bailey (1971) noted that in many pathologically proven SSS
thrombosis, the thrombus was oldest in the middle fifth of the sinus and
in some cases only the central portion was involved suggesting
involvement of certain local factors. In this region the superior cerebral
veins enter the sinus in a direction opposite to the direction of blood flow
in the sinus. Also there is sudden widening of the sinus at this point and
may contribute to the localisation.
5. Theory of hypercoagulability
The hemostatic balance changes in the direction of
hypercoagulability, thus decreasing bleeding complications in connection
with delivery. The most important initial factor for acute hemostasis at
delivery is, however, uterine muscle contractions, which interrupt blood
flow.
        Increased endogenous thrombin generation, acquired protein C
resistance, slightly decreased activated partial thromboplastin time
(aPTT) and increased prothrombin complex level (PT) measured as INR
of less than 0.9, activation of platelets, release of beta thromboglobulin
and platelet factor 4 and increased thrombomodulin levels have been
reported in normal pregnancy. Most blood coagulation factors and
fibrinogen increase during pregnancy. Factor XI is the only blood
coagulation factor that decreases during Pregnancy.
            Fibrinolytic capacity is diminished during pregnancy, mainly
because of markedly increased levels of plasminogen activator inhibitor 1
(PAI-1) from Endothelial cells and plasminogen activator inhibitor-2
(PAI-2) from the placenta. The total hemostatic balance has been studied
by analysis of prothrombin fragment 1 and 2, thrombin-antithrombin
complex, fibrinopeptide a, soluble fibrin, D-dimer and plasmin-
antiplasmin  complex.  There  is  activation  of  blood  coagulation  and  a
simultaneous increase in fibrinolysis without signs of organ dysfunction
during normal pregnancy. These changes increase as pregnancy
progresses.
         Fibrinolysis improves and increases fast following childbirth and
expulsion of the placenta, resulting in increased D-dimer levels. These
changes are self limiting at normal delivery. The hemostatic changes
normalize after delivery within 4 to 6 weeks. Platelet count and free
protein 8, however can be abnormal for a longer Period. 27-32
Pathology
        Hemorrhagic infarction occurs in approximately 10-50% of cases,
principally affecting the cortex and adjacent white matter.24, 33 This is
thought primarily due to elevated venous and capillary pressure caused by
the persistence of thrombus.
Clinical features of cerebral venous thrombosis
          Clinical features of CVT are very variable and depend on the site,
extent and rate of thrombosis. If the symptoms are restricted to the dural
sinuses, it may present with symptoms of raised intracranial tension. If
the cortical veins are involved, focal deficits and seizures may be the
presenting features.34
SYMPTOMS AND SIGNS
Headache
            This is the most prominent and frequently presenting symptom in
70-80% of the patients.35 There are no specific features. It may be acute,
like a thunderclap headache, 36 or  sub  acute  or  chronic.  In  most  of  the
cases, it is associated with nausea, vomiting and other neurological
symptoms. It is probably caused by leakage of blood to the surface
stimulating pain-sensitive fibers in the Dura or due to rise of intracranial
pressure37.
           Isolated headache can be the only manifestation of CVT35. It is
often unilateral, ipsilateral to lateral sinus thrombosis. Whether it
represent a benign form of CVT that would have spontaneously recovered
or the onset of a thrombosis stopped by heparin remains unknown but this
uncertainty justies early diagnosis and urgent heparin treatment.
Fever
         This is often present with septic CVT or those secondary to
systemic infections. Although not mentioned as an important feature in
two large international Studies38, it is frequently seen in Indian patients41,
42. Pyrexia is noted in 15-60% of such cases, does not necessarily imply
infection and is probably caused by an aseptic thrombotic process.43, 44
Superior sagittal sinus (SSS) thrombosis in infants and children may
present only with fever and convulsions which may be confused for
febrile seizures.
Seizures
           These occur more frequently in CVT than in arterial stroke. They
are very common and often begins early, may be focal or generalized and
present in 50% of cases. Their early appearance is a sign of bad
prognosis45. The seizures may be recurrent and may be followed by
aphasia and hemiparesis. Seizures may be focal, modal or generalized,
and  are  commonly  due  to  ‘irritation’  of  the  cortex  when  there  is  a
hemorrhagic venous infarct. Status epilepticus may follow in some cases
and at times, it is the presenting feature. It’s incidence varies from as low
as 3.5% to as high as 42% in two Indian series.47,48
Focal deficits and impaired sensorium
         Focal signs vary with extent and site of thrombosis. They may be
motor or sensory, unilateral or bilateral, and fluctuating. They are seen in
approximately 60% of Cases.49 Altered sensorium is usually due to raised
intracranial pressure (ICP) which is often preceded by headache and
severe focal deficits. Although moderate drowsiness is usually reversible
with  therapy,  progressive  worsening  of  sensorium  is  associated  with  a
poor prognosis. Aphasia, mutism and cerebellar infarcts are also
described.
         Cranial nerve palsies are uncommon; but a total ophthalmoplegia is
seen with cavernous sinus thrombosis and ninth and tenth nerve palsies
with thrombosis of the internal jugular vein.49 Hemiparesis  usually with
facial sparing, as facial area is drained by slyvian vein. The lower limb is
affected more often than upper limbs. In some cases of superior saggital
sinus the contralateral cortical veins may be involved giving rise to
contralateral paraparesis or paraplegia.
Pappiledema
            Thrombosis of the dural venous sinuses leads to an increase in
venous  pressure  and  alters  the  pressure  gradient  leading  to  poor  CSF
absorption through the pacchionian granulations. Hence there is rise of
ICP and pappiledema. The incidence of pappiledema is variable and
depends on the aetiology, rate and site of venous thrombosis. It is less
common in puerperal CVT with acute presentation of headache, seizures,
focal deficits and altered sensorium. The incidence amongst Indian
patients varies from 7.4-55%.34,36,50 However, in cases with subacute
onset a clinical picture stimulating idiopathic intracranial hypertension
can be as high as 83-100%.13,36
              Other uncommon clinical features are signs of meningeal
irritation, cortical blindness, akinetic mutism, dystonia and associated
venous thrombosis in the lower limbs or other parts of the body. Nagaraj
et al.50 grouped clinical features of CVT into four categories, depending
on the topographic venous involvement.
Group-I: Meningo encephalitic type: headache, fever, seizures,
     altered sensorium, focal deficits, meningeal signs.
Group-II: Acute fulminant type :status epilepticus, coma.
Group-III: Pseudo tumour type : headache ,vomiting , pappiledema
Group-IV: Neuropsychiatric type : abnormal behaviour, with or
        without features of raised intracranial tension.
Cavernous sinus thrombosis
             It is due to spread of infection from face, paranasal sinus or
intracranial venous sinuses. It has a distinctive clinical picture where
patient Presents with fever, chills, toxemia with proptosis, chemosis and
painful opthalmoplegia, initially unilateral but often becoming bilateral.
Pappiledema and retinal hemorrhages indicate retinal vein thrombosis.
In  a  study  conducted  by  ameri  et  al.51 in a series of 110 patients
with CVT, main signs and symptoms reported are the following
TABLE 2: CLINICAL FEATURES OF CEREBRAL VENOUS
THROMBOSIS BY AMERI et al
SI NO CLINICAL FEAUTURES Ameri et al. (1992)
N=110(%)
1 Head ache 83 (75%)
2 Papilloedema 54 (49%)
3 Motor or sensory deficit 38 (34%)
4 Seizures 41 (37%)
5 Altered sensorium 33 (30%)
6 Dysphasia 13 (12%)
7 Cranial nerve palsies 13 (12%)
8 Cerebellar incoordination 3 (3%)
9 Nystagmus 2 (2%)
10 Hearing loss 2 (2%)
11 Cortical signs 3 (3%)
In a recent Dutch European study, the most frequent symptoms and signs
were:
 1. Headache                              - 95%
 2. Pappiledema                         - 49%
 3. Seizures                                 - 47%
 4. Motor/sensory deficits           - 34%
 5. Changes in consciousness      - 30%
 6. Dysphasias                            - 12%
 7. Cranial nerve palsies             - 12%
 8. Nystagmus                             - 2%
 9. Deafness                                - 2%
TABLE3: CLINICAL FEATURES OF CEREBRAL VENOUS
THROMBOSIS
Sl.
No Clinical Features
Nagaraja50
(1980)
N=138(%)
Bansal40
(1983)
N=135(%)
Srinivas11
(1987)
N=200(%)
    1 Fever           62          16          11
    2 Headache           48          24          57
    3 Vomiting           36          24           -
Seizures
(a) GTCS           29          50          35
(b) Focal           17          22          23
    4
(c) Status epilepticus            -           -          14
  5 Diplopia          1         -           -
  6 Dysphasia         25        5         -
  7 Nuchal rigidity          3        10        13
  8 DVT         10        -          -
  9 Altered sensorium         41        43        81
  10 Pappiledema         35        16        14
  11. Ocular palsy          -         2        11
Motor deficit
(a) Monoplegia          5         9         -
(b) Hemiplegia         53        37         -
  12.
(c) Paraplegia         27         3
COMPLICATIONS
1. Increasing venous congestion raises cerebrospinal pressure if
collateral drainage is insufficient.
2. Parenchymal edema with infarction, hemorrhage complicates 50%
case.
3. Seizures may persist requiring continued antiepileptics.
4. Pulmonary embolism is uncommon but carries a poor prognosis.52
5. Hypopituitarism may result from cavernous sinus thrombosis.
6. Dural sinus thrombosis has  an etiological association with dural A-V
fistulas.
INVESTIGATIONS
Computed tomography
             CT scanning with and without injection of contrast material is
usually the first neuroimaging examination carried out in patients with
headache, focal deficits or seizures, particularly on an emergency basis.
CT scanning is extremely useful for ruling out many CVT mimics. It
occasionally detects lesions that can themselves cause CVT such as
meningiomas, abscesses, sinusitis, and mastoiditis. CT scanning is also
useful in showing brain or sinus changes suggestive of CVT.
Direct signs of cerebral venous thrombosis
          Three abnormalities are considered direct signs of CVT:
1. The cord sign, 2.The dense triangle sign and 3. The empty delta sign.
         Plain CT cord sign 53, 54: Represents the thrombosed cortical vein.
It appears as a linear hypodense streak in location of involved vein. It
represents acute or new thrombus, thus seldom seen in chronic cases. The
cord sign, visible on unenhanced CT scan, represents the spontaneous
visualization of a thrombosed cortical vein; it is very rare and its
diagnostic value is debated. The cord sign can also be seen in thrombosis
of the internal cerebral veins and of the vein of galen.
          Dense triangle sign53, 54: Triangular area of increased density along
course of superior sagittal sinus and represents opacification by freshly
coagulated blood. It is rare and usually seen in the first two weeks of the
disease. It is a very early sign but an extremely rare one, being present in
less than 2% of cases. The dense triangle is difficult to assess, particularly
in other sinuses (lateral sinus and straight), which can be spontaneously
hyper dense in normal children or in patients with hemo concentration.
The  empty  delta  sign described by Buonanno and colleagues54
appears after injection of contrast material. It reflects the contrast
between the opacified collateral veins in the SSS wall and the non-
opacification of the clot inside the sinus. It is the most common direct
sign, present in approximately 35% of published cases.
             The empty delta sign is absent, however, when (1) thrombosis
does not affect the posterior third of the SSS or (2) CT scanning is
performed either in the first 5 days or more than 2 months after onset of
symptoms.
Indirect signs of cerebral venous thrombosis:
Indirect and nonspecific abnormalities are more common in CVT.
a. Cerebral edema. White matter hypo density without contrast
enhancement suggestive of cerebral edema is present in up to 75% of
cases. It can be diffuse· or localized and sometimes associated with a
mass effect. This finding is usually associated with abnormalities
suggestive of a venous infarct, but it can occasionally be the only sign of
CVT.
b. Cerebral infarction not conforming to an arterial territory: Usually
described by pathologists as hemorrhagic, venous infarcts on CT scan
manifest as a spontaneous hyper density in 10% to 50% of cases.
c. Small ventricles: A common finding is the presence of small ventricles
with  swelling  and  sometimes  diffuse  low  density   suggestive  of  edema.
Although reported in 20% to 50% of cases, this finding is not a useful
sign because it is non-specific and is frequently difficult to differentiate
from normal brain, particularly in the young.
d. Gyral and Tentorial enhancement: Tentorial enhancement is usually
thought to suggest SS thrombosis but it is not rare in SSS thrombosis. It
can be associated with dilated transcerebral medullary veins, indicating a
major venous stasis, usually in relation to an extensive SSS thrombosis.
e. Non-hemorrhagic venous infarcts: They are almost as common. They
are protean in appearance, taking the form of focal hypo density with
gyral enhancement, areas of hypo density without enhancement or non
hemorrhagic infarcts which can be unilateral or bilateral single or
multiple. They are seen superficially in the hemispheres in SSS
thrombosis and within the basal ganglia in deep venous system
thrombosis.
f. Bilateral signs
g. Subarachnoid hemorrhage
h. Subdural hematoma
i. Normal CT scan in CVT
        In 10% to 20% of cases, CT scanning is normal in patients with
proven CVT, more commonly (up to 50%) in patients presenting with
isolated intracranial hypertension than (<10%) in those with focal
signs52,53.  The place of CT scanning in the diagnostic strategy of CVT is
mainly to rule out other conditions, such as arterial stroke, abscess,
tumors, and subarachnoid hemorrhage on an emergency basis. However,
MRI or angiographic confirmation must be obtained.
          Thrombosis most frequently affects (in order of decreasing
frequency) the SSS, LS and cavernous sinus.
FIG-3 PLAIN CT-- DENSE TRIANGLE SIGN
Axial unenhanced CT images show a “dense triangle” sign
(arrowhead) in SSS and a cord sign (arrow), showing cortical vein
thrombosis.
FIG 4-EMPTY DELTA SIGN
Contrast-enhanced CT image reveals low-attenuating thrombus
(arrow) within the superior sagittal sinus, surrounded by a triangular area
of enhancement.
Fig 5-BILATERAL HEMORRHAGIC INFARCT
Plain CT scan of head in axial plane shows hemorrhagic infarcts in
bilateral parieto occipital lobes.
Magnetic resonance imaging (MRI) in venous thrombosis
    MRI offers the following major advantages for the evaluation of
possible CVT sensitivity to blood flow, ability to visualize the thrombus
itself, and non invasiveness. A variety of MRI findings have been
described.
1. In acute phase- Normal venous flow void is absent, and the occluded
vessel appears isointense on T1weighted images and hypo intense on T2-
weighted images. The diagnosis at that stage is often impossible on MRI
alone. Angiography (or MRV) is required to demonstrate the absence of
flow in the thrombosed vessel.
2.  During 5-15 days the absence of flow void persists, but the thrombus
becomes hyper intense, initially in T1 and then on T2 weighted images.
In large vessels, these changes start in the periphery and proceed toward
the center. They represent the aging of the thrombus with biochemical
conversion of oxyhemoglobin to methemoglobin rather than extension of
thrombosis.
This intermediate pattern signal on T1-and T2 weighted images is
diagnostic of CVT and is by far the most common. It is usually found
between 4-35 days after the onset of symptoms.
3. Late changes (approximately 2 to 4 weeks after onset)
It can reveal the beginning of vascular recanalization with the
resumption of flow void in the previously thrombosed vessel.
         However,  at  6  months,  more  than  two  thirds  of  cases  still  show
some heterogeneous localized signal abnormalities, which can persist for
years and should not be mistaken for a recurrent acute CVT.
         Besides  visualizing  the  thrombus  itself,  MRI  detects  the
parenchymal consequences. These include brain swelling with mass
effect and cortical sulcal effacement; increased signal on T2 weighted
images with isointense or hypo intense signal on T1 weighted images
suggestive of edema and increased signal on both T1 and T2 weighted
images, indicating a hemorrhagic component. These findings are
nonspecific, but their diagnosis is easy because of the associated MRI
signs of sinus thrombosis. The main difficulty is with isolated cortical
vein thrombosis, which can be mistaken for a tumor unless angiography
demonstrates typical stop sign with corkscrew collateral veins.
          Diffusion-weighted imaging (DWI) seems to have several
advantages. First, the clot can be directly visualized as high signal
intensity in the affected sinus. Second, the diffusion pattern in the venous
infarcts is different from that in arterial infarcts. The most common
pattern is heterogeneous signal intensity with a normal or increased
apparent diffusion coefficient (ADC) corresponding mostly to vasogenic
edema combined with some areas of cytotoxic edema.
         Commonest venous channels involved in CVT in MRV are 57:
 1. Superior sagittal sinus thrombosis - 72%
2. Transverse sinus thrombosis - 70%
3. Straight sinus - 14%
4. Deep sinus - 8%
5. Cavernous sinus - 3%.
6. Cerebral veins - 38%
Superficial - 27%
Deep - 8%
Cerebellar veins - 3%
ANGIOGRAPHY
Intra-arterial angiography
          Angiography had been the key procedure in the diagnosis of CVT
for many years and remains the method of reference in some difficult
cases. It requires four-vessel angiography conventional or digitized intra-
arterial. The partial or complete lack of filling of veins or sinuses is the
best angiographic sign of CVT. It is easily recognized when it affects the
posterior or whole SSS, both lateral sinuses and the deep venous system.
The lack of filling may be more difficult to interpret in other locations,
such as the anterior third of the SSS or the left lateral sinus. However, in
such cases, signs are lacking and MRI is required to differentiate between
thrombosis and hypoplasia.
         Another angiographic finding is delayed emptying, collateral
venous pathways, found in about 50% of cases, almost invariably indicate
SSS  thrombosis.  Dilated  and  tortuous  cortical  collateral  veins  with  a
corkscrew appearance are much more common than transcerebral or intra
dural collateral vessels.
Magnetic resonance venography
           The current practice is to use noninvasive magnetic resonance
venography (MRV) instead of intra-arterial angiography for the diagnosis
of CVT. A four vessel angiography with venous phase films taken at
intervals of 5-12 seconds of contrast injection.  Frontal, lateral, oblique
views are taken in order to visualize the entire venous system. Delayed
venous films may be necessary to allow for slow venous filling in patients
with raised intracranial tension. Angiography becomes necessary if
thrombolytic therapy is considered.
Findings
1. Failure to demonstrate all or part of sinus / vein or localized
irregularity within its wall.
2. Non filling of cortical veins.
3. Focal or diffuse slowing of circulation and stagnation of coagulated
blood in capillary or venous phase.
4. Corkscrew vessels that do not reach cortical surface due to dilatation of
anastomotic vein over cortex.
5. Parenchymal changes include:
- Focal or diffuse brain swelling with sulcal effacement
- Intracranial hemorrhage
- Ventriculomegaly due to decreased cerebrospinal fluid, a
consequence of increased resistance of CSF resorption by
the arachnoid granulations.
Helical CT venography
          Helical cerebral CT venography has been developed to study the
venous circulation. Filling defects, sinus wall enhancement, abnormal
collateral venous drainage and tentorial enhancement are common
abnormalities. It has been suggested that CT venograms are easier to
interpret and have fewer artifacts than MRV. CT venography is
particularly interesting in the acute setting because it can be easily
performed immediately after contrast-enhanced CT, which is usually the
first procedure performed in emergencies.
IV. Radionuclide Scanning: Dynamic radionuclide scanning has been
utilized for visualization of venous dural sinuses, but lacks sensitivity and
specificity.
V. Other Investigations
1. CSF examination: It is of diagnostic use .It is performed in suspected
benign intracranial hypertension, to rule out CVT associated with
infections, carcinomatous meningitis etc .It may reveal non specific
changes like raised proteins ,cells and pressure.
2. Appropriate tests towards etiogenesis like:
v Complete blood count may reveal anemia, polycythemia,
leucocytosis, and thrombocytopenia.
v Lupus anticoagulant and anti cardiolipin antibodies.
v Protein C and S,Antithrombin III, Factor V Leiden mutation.
v Homocysteine.
v ESR, ANA ACL AB tests in connective tissue disorder.
v ANCA in Wegener’s granulomatosis
v Urine for protein
v Liver function test
v D-dimer58
v ECG, ECHO, EEG
FIG 6-LEFT TEMPORAL HAEMORRHAGIC INFARCT
Axial T2-Weighted Image Reveals Left Temporal Lobe T2
Hyperintensity  Consistent  with  Infarction  and  a  Central  Focus  of  T2
Hypointensity (Arrow) Due to Hemorrhagic Venous Infarction.
FIG-7 MAGNETIC RESONANCE VENOGRAM
Magnetic resonance venogram demonstrating occlusion of the left
sigmoid and transverse sinuses.
TREATMENT
General Measures:
Include routine measures for care of comatose patient and includes:
1. Maintenance of airway patency.
2. Maintenance of fluid and electrolyte balance.
3. Prevention of infections and gastric ulcers.
Symptomatic Treatment:
v Seizures: Antiepileptics are obviously indicated in patients with
clinical seizures.
2. Cerebral edema: Cytotoxic edema results due to alteration in
biochemical mechanism at cellular level. It is followed by vasogenic
edema in 24-48 hours Measures to control cerebral edema and raised intra
cranial tension are:
v Head end elevation to 30 degrees to promote venous drainage.
v Mannitol (20%)-in dose of 0.25-1g/kg i.v over period of 10minutes
v Dexamethasone given in a dose of 4mg every 6 hours. It primarily
reduces vasogenic edema.
v In a patient with large venous infarcts with mass effect raises the
intracranial pressure considerably and if vision continues to
deteriorate, in such cases besides starting mannitol, oral glycerol or
acetazolamide, intravenous steroids repeated lumbar puncture and
surgical decompression like lumboperitoneal shunt have been
suggested58.
Etiologic treatment
          Whenever possible, etiological cause of CVT should be treated. It
includes wide spectrum antibiotics for septic CVT and surgical
debridement for primary site of infection. Malignancies, collagen
vascular disease and hematologic disorders need specific treatment.
Antithrombotic treatment
          Although heparin was first recommended 6 years ago, some were
skeptical about its use owing to the fear of further hemorrhage into
hemorrhagic infarcts. However there is ample evidence favoring the use
of heparin for patents with CVT even if there are hemorrhagic infarcts in
CT or MRI.59,60,61 Anticoagulants are used to prevent propagation of the
clot to more extensive areas of cerebral venous system and thereby
prevent progression of infarction. Neonatal CVT is the only situation in
which heparin has not been shown to improve the outcome and most
authors do  not recommend its use in this situation (Nagaraja61, Sarma
2002). The antithrombotic treatment modalities include heparin,
thrombolysis and oral anticoagulants.
A. Heparin: Increases the action of antithrombin III, leading to
inactivation of coagulation factors thrombin, factor Xa and IXa.
DOSE: Most studies have used higher doses of heparin.   The dose of
heparin used should result in aPTT twice of the baseline. Both low
molecular and unfractionated heparin are equally efficacious.  Heparin is
given parenterally for 2 weeks followed by oral anticoagulants for 3-6
months. Unfractionated heparin can be given either by subcutaneous or
continuous IV infusion.
B. Warfarin: Acts by interfering with the action of vitamin K, a cofactor
essential for converting precursor proteins into factors 2,7,9,10.
It is used for 3-6 months following parenteral heparin. Dose is
5mg/day; dose adjusted by monitoring prothrombin time and INR.The
dose is adjusted to obtain an INR between 2 and 3.
Oral  anticoagulants  are  continued  for  6  months  when  there  is  a
known acute cause of CVT like postpartum state, minor head trauma or
local infection. In contrast, prolonged treatment is recommended when
there is continuing risk of thrombosis as with inherited thrombophilia,
prothrombotic states associated with malignancies and inflammatory
disorders like behcet’s disease or systemic lupus erythematosis.
Thrombolytic therapy
          Intravenous urokinase was used for CVT, first by Vines and Dand
in 1971 and ten years later by Di rocco and colleagues; direct
endovascular thrombolytic agents like urokinase, RT-PA are being
administered into dural sinuses for recanalisation. Two series totaling 21
patients have been reported in literature of its use in dural sinus
thrombosis 62, 63 administered through jugular catheter. In most cases
outcome was good. Nevertheless both carry a risk of hemorrhage being
advocated especially in patients in whom the medical therapy has failed.
Surgery
             Surgical decompressive craniotomy, thrombectomy and
evacuation of intracerebral hematoma need further evaluation before it is
recommended as a safe procedure. Out comes are usually poor.
OUTCOME
Short term outcome
The three main causes of death in CVT are:
1)  Brain lesion itself, particularly when a large hemorrhagic infarct is
present
2)  Intercurrent complications like sepsis, uncontrolled seizures and
pulmonary Embolism
3)  Underlying conditions like carcinoma, septicemia, leukemia and
paroxysmal nocturnal hemoglobinuria.
Factors classically considered to suggest a bad prognosis are as follows:
• Rate of evolution of thrombus
• Age of the patient
• Infection as a cause
• Focal symptoms and coma
• presence of hemorrhagic infarct
• Empty delta sign on CT scan
• Topography of cerebral veins involved.
Among all underlying conditions, the postpartum state is a
favorable one with a survival of 90% in most series.
Long term outcome
            If  the  patent  with  CVT  survives,  the  prognosis  for  recovery  of
function is much better than for patients with arterial thrombosis.
Residual epilepsy has been reported in 10-30% of patents who had
seizures during the acute stage of CVT. Recurrence of venous thrombosis
at another site can occur in patents with prothrombotic states, but is
generally uncommon with long term anticoagulation.
           One hundred of 138 cases of cerebral venous thrombosis related to
pregnancy and the puerperium recovered completely in the series of
Bansal et al.64,  Srinivasan  et  al65 observed that of 135 patients (129
venous thrombosis and 6 Arterial thrombosis) in pregnancy and
puerperium80 recovered without significant neurological deficit. Fifty of
these cases followed-up for two years were doing well. Ten patients had
residual focal neurologic deficit without disability; 10 were active but had
recurrent though infrequent seizures. Stanisfile66 on the basis of 16 cases
from literature reported a mortality rate of 56%, Warle kendall67 gave a
figure of 30%.
MATERIALS AND
METHODS
METHODOLOGY
                   Forty (40) patients admitted to the Medical Emergency Ward,
clinically suspected of CVT, during the period of September 2010 to
September 2011 were subjected to neuro imaging techniques, fulfilling
the study criteria were recruited by simple random sampling and data
collected was analyzed by correlation studies.
Study Design
Prospective, clinical study with CT or MRI
Study center
Institute of Internal medicine at Government General Hospital
(GGH), Chennai
Selection of patients
Inclusion Criteria:
        40 consecutive patients presenting with history suggestive of
cerebral venous thrombosis and  CT scan direct and indirect signs
confirmed by imaging of brain (MRI & MRV).
A. Direct Signs
  a. Hyperdense sinus on plain CT
  b. Cord sign on plain CT
  c. Empty delta sign on contrast enhanced CT
  d. Dense triangle sign on plain CT
B. Indirect Signs
  a. Cerebral edema
  b. Cerebral infarction not conforming to an arterial territory
  c. Small ventricles
  d. Bilateral signs
  e. Gyral enhancement
  f. Tentorial enhancement.
Exclusion Criteria:
1. CT scan inconclusive of CVT
2. Hypertensive hemorrhage
3. Arterial stroke
4. Metabolic encephalopathy
5. Space occupying lesions.
           Data was collected by using pre-tested proforma meeting the
objectives of the study.  Purpose  of  the  study  was  carefully  explained  to
the patients and informed consent was taken. All patients were
interviewed. Detailed history was taken with respect to epidemiological,
clinical features, radiological features, with special emphasis on
suspected precipitating or predisposing factors such as puerperium, fever,
sepsis, anemia, abortions and oral contraception.
             Detailed examination of patients was carried out including
general physical examination for any evidence of anemia, dehydration,
sepsis, deep vein thrombosis of leg and detailed neurological assessment
with other systems were done to look for any evidence of etiologies.
OBSERVATIONS AND
RESULTS
OBSERVATION AND RESULTS
A total of 40 cases of cerebral venous thrombosis were evaluated in
the Present study.
1. Age distribution
TABLE 4- AGE INCIDENCE
              The mean total cohort age is 30.05.the mean age for puerperal
age group is 25.62.
Sl.No. Age in years Number of cases Percentage
1 15-24 8 20
2 25-34 22 55
3 35-44 8 20
4 45-60 2 5
FIGURE 8: AGE INCIDENCE
The mean age of the patients in the present study was 30.05%.
Majority of them were in the age group 15-35 years contributing to 75%.
The youngest age being 20 and highest is 55 years.
2. Sex distribution
TABLE 5- SEX INCIDENCE
Sl.
No. Sex
Total number
of cases
(n=40)
Percentage
1 Females 16 40
2 Males 24 60
3. Types of CVT
TABLE 6- TYPES OF CVT
Category
Total number of
female cases(
n=16)
Percentage
in female
cases
Percentage in
total
study.(n=40)
Puerperal 14 87.5 14 (35%)
Non puerperal 2 12.5 26(65%)
There were 24 men (60%) and 16 women (40%) in the study. Out
of 16 female patients, 14 (87.5%) were puerperal and 2 (12.5%) were non
puerperal CVT.
FIG 9-SEX  INCIDENCE
MALE
FEMALE PUERPERAL
NON PUERPERAL
Here male: female ratio is 1.5:1. In the present study, out of 40, 26
(65%) patients belong to non puerperal group and 14 (35%) belong to
puerperal group.
4.  Mode of onset
Those who presented within 48 hours were considered to have
acute onset,with onset longer than 48 hours but less than 1 month were
considered subacute, and with onset more than 1 month as chronic
(bousser et al., 1985)
TABLE- 7: MODE OF ONSET
Mode of onset Number of
cases
Percentage
Acute 12 30
Sub acute 26 65
Chronic 2 5
FIG 10-MODE OF ONSET
         In  the  present  study,  26  cases  (65%)  of  CVT  had  sub  acute
presentation, followed by 12 cases (30%) with acute presentation and 2
(5%) cases had chronic presentation.
5. Level of consciousness at the time of presentation
TABLE 8- LEVEL OF CONSCIOUSNESS
Level of consciousness No. of patients (n=40) Percentage
Conscious 14 35
Drowsy 12 30
Stuperous 8 20
Comatose 6 15
In the present study, patients presented with full consciousness
include 14 cases contributing 35%. 12 cases were drowsy with 30%
incidence.8 (20%) were stuperous  and 6 (15%) came with coma.Death is
common in comatose patients.
CLINICAL SIGNS AND SYMPTOMS
6. Initial onset of symptoms
Patients with initial symptom of presentation was taken into
consideration.
TABLE 9- INITIAL SYMPTOMS
Symptoms Number of cases Percentage
Headache 36 90
Convulsions 32 80
Altered sensorium 26 65
Focal deficits 22 55
Fever 18 45
In the present study, most common symptom was headache
contributing to 87.5% (36 cases) followed by convulsions in 80% (32
cases).Two of them had ear discharge and another with diarrhea.
FIGURE 11: INITIAL PRESENTATION
In our study, 65% presented with altered sensorium, 55% with
focal deficits, 45% with fever.
7. Neurological signs
TABLE 10- NEUROLOGICAL SIGNS
Signs Number of Cases Percentage
Focal deficit 22 55
Disk bulge 12 30Fundus
Pappiledema 8 20
Cranial nerves 14 35
In the present study, hemiplegia was present in 55%, cranial nerve
involvement in 35% and Pappiledema in 20% of patients.
INVESTIGATIONS
8. Hemoglobin percentage
TABLE- 11: HEMOGLOBIN PERCENTAGE
Hb% Number of cases Patients alive Patients dead
2-5 1 1 -
5.1-8 6 5 1
8.1-10 10 8 2
> 10 23 18 5
In the present study, out of 40, 17 patients were anemic, accounting
for 42.5%. The maximum number of deaths appears to be more with
HB% > 10 g%, and the percentage of mortality was higher in non anemic
group.All patients who died with mild and moderate anaemia were in the
puerperal group.
9. CSF Analysis (done in 18 patients)
TABLE 12: CSF ANALYSIS
CSF changes Number of  Patients
Normal 8
Protein rise 4
Pleocytosis 6
Xanthochromia 2
Eighteen (18) patients were subjected to CSF analysis whenever
there  was  suspicion  of  meningitis  of  which  8  were  normal  and
abnormality seen in rest 10 patients with pleocytosis being the maximum.
Two patients had TB meningitis.
FIG 12-CT SCAN FINDINGS
INDIRECT
DIRECT
NORMAL
10. CT Scan findings
TABLE 13: CT SCAN FINDINGS
Signs Number of Cases Percentage
Cord sign 4 10
Empty delta sign 3 7.5
Dense triangle sign 1 2.5
Mass effect 5 12.5
Midline shift 5 12.5
Bilateral infarct 3 7.5
Edema 8 20
Hemorrhagic infarct 22 55
Non-haemorrhagic infarct 2 5
Normal 4 10
In the present study, Haemorrhagic infarct comprises 22 cases with
55% followed by edema in 20%.Out of 40 patients 10% had normal CT
picture. Indirect signs (70%) were more common than direct signs (20%).
11. Sinuses involved in MRI+ MRV.
All 40 cases, including 10 patients with normal CT scan findings
underwent MRI scan.
TABLE 14: SINUS INVOLVED IN MRI+MRV
Sinus involved Number of Cases Percentage
Superior sagittal sinus 24 60
Transverse sinus 20 50
Straight sinus 3 7.5
Sigmoid sinus 12 30
Cavernous sinus 2 5
Cortical vein 2 5
Internal jugular vein 1 2.5
Deep cerebral vein - -
FIGURE 13: SINUS INVOLVED IN MRI + MRV
In the present study, the most common sinus involved was superior
sagittal Sinus in 24 patients accounting to 60% followed by transverse
sinus in 20 Patients 50%.
12. Predisposing or etiology factor
Predisposing/ etiology factor were identified in 25 (62.5%) of
patients. In 15 (37.5%) risk factor could not be identified.
Rheumatological evaluation was done only in 10 patients because of cost
restraints. Also we found 11 patients had the habit of using smoke and
alcohol,  4  were  only  smokers,  1  was  an  alcoholic  and  6  were  pan
chewers. All these lead to hypercoagulable state.
Infections-7
HIV-2
TBM-2
CSOM-2
Diarrhoea-1
Non Infectious
Hyperhomocysteinemia-17
APLAS-2
Protein C/S deficiency-1
Puerperal -14
PIH-2
13. Clinical outcome
TABLE 15: TOTAL MORTALITY
Category No of patients Mortality Percentage
Male 24 5 12.5
Puerperal 14 3 7.5Female
Non-puerperal 2 - -
In this study of 40 patients, 32 were alive attributing to 80% and 8
died comprising 20%. 12.5% died in non-puerperal group and 7.5% died
in the puerperal group.
DISCUSSION
DISCUSSION
             The first description of CVT was by Ribes11 in  1825  as  a
postmortem report in French literature. Most of the initial reports are
from autopsy findings and it was found to be extremely low.  Ehlers14
found only 16 SSS thrombosis in a 12500 autopsy series. Kalbag and
Wolf 68indicated that CVT was the principal cause of death in only 1 per
million (21.7 persons per year) in England and Whales between 1952 and
1961.At Nimhans , Bangalore, of the 1760 brains examined 75 were of
primary CVT (Nagaraja et al34).    But  recent  studies  like  Bansal  et  al40,
Rao  et  al46 suggests that the true incidence is much higher than that
thought from the initial autopsy series.
         Cerebral venous thrombosis though not rare, is often undiagnosed
as  it  presents  with  a  wide  array  of  symptoms  .It  mimics  practically  all
neurological conditions. It affects all age groups and has unpredictable
outcome. This condition is common in the Indian subcontinent,
responsible for 10-15% of young strokes.
          It has been reported more commonly in women. Studies by various
Indian authors (Agarwal1978, Srinivasan1983, Banerjee1973, Nagarajan
1988) have highlighted higher prevalence in pregnancy and puerperium.
         Though our study of 40 patients does not give the real incidence of
the disease the fact that they were seen in 1 year at Government general
hospital, Chennai suggests that CVT is not uncommon.
1. Mean Age of onset
TAB- 16: MEAN AGE OF ONSET
Authors name
Mean age of onset
(years)
Daif et al.21 27.8
Nagaraj et al.36 24.2
Strolz e et al.26 32.8
Bousser et al3 40.8
Deschiens et al69 36.2
Zhang et al 71 31
De brujjin et al53 37
Terazzi et al70 44.8
Present study 30.05
          Comparing the age group involved, 15-35 years was the
commonest age group involved in various series. The present study also
showed similar findings with 75% in the same age Group, with mean age
of onset 30.05 years which is comparable with Zhang et al., Strolz e et al.
It is found that the lower mean age of onset (25.62) is correlated with
puerperal age group
2. Age Distribution
TABLE-17: AGE DISTRIBUTION
Age in yearsAuthor
15-24 25-34 35-44 45-60
Carol et al22 25% 50% 25% -
Bansal et al40 15.9% 65.2% 18.8% -
Bousser et al3 5.3% 26.3% 18.4% 50%
Deschiens et al69 5% 27.5% 37.5% 30%
Present study 20% 55% 20% 5%
          The  age  distribution  in  our  study  is  similar  to  most  other  studies.
About  75%  of  the  patients  in  our  series  had  onset  between  15  and  34
years of age.  20%of the patients had onset between 15and 24. Most of
these cases were puerperal.
2. Sex distribution
TABLE -18 : SEX DISTRIBUTION
Author males females
Bousser et al6 21 (55.3%) 17 (44.7%)
Daif et al.21 20 (50%) 20 (50%)
Deschiens et al69 10 (25%) 30 (75%)
Zhang et al71 9 (39.1%) 14 (60.9%)
De brujjin et al25 9(16.3%) 50 (84.7%)
Terazzi et al70 10 (30.9%) 38 (70.1%)
Present study 24 (60%) 16 (40%)
         In our study sex distribution is almost similar to Bousser et al, Daif
aet al. Most of the other studies reported as increased female incidence.
Here ratio of male: female is 1.5:1
3. Types of CVT patients
          In the present study, out of 40, 26 (65%) patients belong to non
puerperal group and 14 (35%) belong to puerperal group.
Only  1  (2.6%)  of  the  38  patients  of  Bousser  et  al6 was puerperal
while  in  Deschiens  et  al  study  only  8(20%)  of  patients  were  puerperal.
Only 1 (2.5%) of Daif et al. was post partum.4 (21.5%) of 19 patients of
Zuber et  al  was related to pregnancy.  Similar  to these most  of  our cases
were non-puerperal. This is because there is no obstetric department in
our hospital and cases have to be referred from outside.
This is in contrast to previous Indian studies. Nagaraj et al. (1987)
had found that 200 out of 230 cases (86%) of CVT, seen over eight years,
were puerperal in nature.  In a study by Srinivasan et al 25% maternal
mortality is in CVT patients and complicate 4.5% of obstetric admissions.
SYMPTOMS AND CLINICAL FINDINGS
4. Mode of onset
          In  the  present  study,  26  cases  (65%)  of  CVT  had  sub  acute
presentation, followed by 12 cases (30%) with acute presentation and 2
(5%) cases had chronic presentation.It is correlated with Nagaraj et al.
(1987), Strolz e et al. (2005).
5. Level of consciousness
       Comatose, drowsy and stuperous patients were calculated as patients
with altered sensorium.
TABLE- 19: LEVEL OF CONSCIOUSNESS
Authors
Number of
Cases studied
Percentage with Altered
Sensorium
Bousser et al.(1985)3 38 26
Nagaraj et al. (1987)37 200 81
Ameri et al. (1992)72 110 30
Nagaraj et al. (1999)61 73 57.53
Neki s et al. (2003)73 14 56
Strolz e et al. (2005)26 79 36.7
Present study 40 65
In  the  present  study,  65%  of  patients  had  altered  level  of
consciousness which is comparable with Nagaraj et al.
5. Headache
         Headache in the absence of intracranial hypertension, subarachnoid
haemorrhage, or meningitis. Such cases are essentially associated with
lateral sinus thrombosis , which should not be mistaken for lateral sinus
hypoplasia.
Headache was the most common symptom in the present study
accounting for87.5% of patients. The present study was comparable with
most other studies like Neki s et al. with 85.5%, Daif et al. with 82% and
mehta et al.74 with 77.8%.
6. Seizures
The manifestations that indicate the cerebral cortical involvement
are convulsions and paralysis, at times seizures are heralding symptoms
and should arouse the suspicion of diagnosis.
TABLE- 20: SEIZURES
Authors Number of Casesstudied
Percentage with
Seizures
Bousser et al. (1985)3 38 29
Nagaraja et al. (1992)50 200 70
Kumar s et al. (2003)75 85 67
Mehta sr et al. (2003)74 43 26.6
Srinivasan et al. (2005)44 135 68
Present study 40 80
In  the  present  study,  80%  of  cases  had  seizures  which  are
comparable with Nagaraja et al, Kumar s et al. In contrast, other studies
showed less compared to present study.
          Nagaraja et al found generalized seizures in 35 % and focal
seizures in 23%, and 14% of them had status epilepticus of 200 patients.
In our study  20% had focal seizures, 45 had generalized 10%with status
and focal seizures with secondary generalisation in 25%.
7. Focal deficits
           In the present study, 55% of patients had focal deficits. Among
them 50% had hemiparesis  and 5% had monoplegia. 35% had associated
cranial nerve palsies, most commonly affected being the VI nerve.  Strolz
e et al. (2005) had found that out of 79 cases, 56.9% cases had
hemiparesis. The present study was comparable with strolz e et al.
8. Papilledema
TABLE -21: PAPILLEDEMA
Authors Number of cases Percentage withpapilledema
Nagaraja et al 200 15
Bousser et al. 38 45
Kumar s et al. 85 32
Neki s et al. 14 80
Mehta  et al. 43 77.8
Daif et al 40 66.7
Present study 40 50
In the present study, 50% of patients had papilledema. Similar
observations were noted with Bousser et al and Daif et al.
INVESTIGATIONS
9. Anemia
           Anemia has often been noted in 17 (42.5%) of patients in the
present study. The total number of deaths appears to be more with HB%
> 10 g%, and the percentage of mortality was higher in non anemic
group. This is because majority of the mortality fall in the non puerperal
group.
         The investigative procedures like leucocytes count, blood sugar,
ESR did not contribute to the diagnosis and were non-specific. Except
five cases where the blood Urea levels were high where patients had
developed pre-renal failure due to fluid restriction.
10. CSF Analysis
              In the present study, CSF analysis done in 18 patients which
showed non-specific changes like Pleocytosis  (> 5 cells/ mm3 in  6
patients), raised proteins (> 45 mg/dl in 4 patients) and xanthochromia (2
patients).In large number of patients, CSF did not contribute to the
diagnosis of CVT except the 2 who had TB meningitis.76
11. CT scan findings
          As discussed earlier CT scan plain and contrast is the first neuro
imaging technique to carry out when CVT is clinically suspected. It is
useful to diagnose CVT and to rule out tumors, infarcts and hemorrhages.
          The  features  primarily  due  to  thrombosis  of  veins  or  sinuses  are
called direct signs and those due to secondary effects on brain
parenchyma are referred as indirect signs.
TABLE- 22: CT SCAN FINDINGS
Signs Rao et al (31) Nagarajaet al (68)
Present study
(40)
Cord sign 6.4 21.9 10
Empty delta sign 35.5 32 7.5
Dense triangle sign - - 2.5
Mass effect - 8.1 12.5
Midline shift - 3.1 12.5
Bilateral infarct - - 7.5
Edema 21.4 19.8 20
Hemorrhagic infarct 19.7 40.9 55
Non-haemorrhagic
infarct
9.7 51.6 5
Normal 9.7 10.9 10
CT scans are normal in 10-20% of the patients in Bousser et al,
Nagaraja et al, Rao et al. In our study 10% had normal CT pictures. 20%
of 40 cases had direct evidence. In our study indirect signs (70%)  were
more common than direct signs (20%). The most common finding is
hemorrhagic infarction present in 55% of cases. Similar observations
noted with various studies like Nagaraj et al. and dixit et al. with 40.9%
and 48.4% respectively.
12. Sinuses involved in MRI
MRI with MRA was done in all 40 patients. It was abnormal in all
the patients.
TABLE- 23: SINUSES INVOLVED IN MRI
Sinuses Ameriet al.
Daif
et al.
Strolz e
et al.
Present
study
Superior sagittal Sinus 72% 85% 72.2% 60
Transverse sinus 70% 2.5% 38% 50
Straight sinus 16% 7% 7.6% 7.5
Sigmoid sinus - 32% 20.3% 30
Cavernous sinus - - - 5
Cortical vein - - - 5
Internal jugular vein - - 7.6% 2.5
Deep cerebral vein 8% 10% 6.3% -
In the present  study,  the superior  sagittal  sinus is  most  commonly
involved77 accounting for 60% followed by transverse sinus with 50%,
comparable with other studies like strolz e et al. (72.2%) and ameri et al.
(72%).
13. Predisposing or Etiology factor
Predisposing/ etiology factor were identified in 25 (62.5%) of
patients. In 15 (37.5%) risk factor could not be identified. Infections were
identified as risk factors in 7 (17.5%) cases. HIV was associated with 2
patients  and  they  had  chronic  onset  of  illness,  TBM  in  2  ,  diarrhea
in1,CSOM in 2 patients. Among non infectious puerperium was the
common predisposing factor, in which 2 patient had PIH. 2 male patients
had APLA (5%)79 and combined Protein C/S deficiency in one patient78.
11 patients were chronic smoker and alcoholic, 4 were only smokers,
1 was an alcoholic and 6 were pan users. Out of this 17 patients had hyper
homocysteinemia. Less marked elevations are proven risk factors for
cardiovascular and venous thrombotic events80. Normal levels 5-15
μ mol/L.
14. Treatment
The role of Heparin in the management of CVT has been a matter
of controversy. It’s effectiveness, even in hemorrhagic venous infarcts
has been extensively studied and recommended by various authors
Einhaupl 199182, Cepri 199883, Nagarajan 199884. Though most series
have  used high dose heparin as a continuous infusion in management of
CVT  ,in the present study all 40 cases were   treated with unfractionated
Heparin 5000 i.v 8th  hourly. All patients received oral anticoagulant for
3months. No complications were detected as a result of treatment
regimen employed in the present study and proved to be effective.
15. Mortality
TABLE- 24: MORTALITY
Author Number of cases Percentage of Mortality
Bansal et al. 138 27.5
Srinivasan et al. 135 25.9
Nagaraj et al 200 21.7
Storlz e et al. 79 15
Present study 40 20
           In  the  present  study,  the  mortality  is  20%  which  is  comparable
with various other studies.
           We followed the case for 2 weeks after diagnosis. Out of 32 alive
cases 12 had recovered completely and the other 20 had residual
weakness. Since the patients were not followed up for longer duration we
could not comment on long term outcome of them.
             Contrary to ischemic arterial stroke, CVT could be described as
an “all or nothing” disease with good short and long term outcomes when
the acute phase of illness has been survived85.
CONCLUSION
CONCLUSION
1. The present study emphasizes that cerebral venous thrombosis is an
important cause of stroke especially in the peripartum settings and
stroke in young.
2. The mode of onset is variable and spectrum of clinical presentation
is extremely wide.
3.  Diagnosis of CVT needs high index of suspicion.
4.  Demonstration of underlying etiology may be difficult  if it is not
clinically evident.
5.  Prompt diagnosis and anticoagulation affects patients outcome.
6. Imaging plays a key role in diagnosing cerebral venous thrombosis,
a condition that can be mimicked by several other neurological
entities.
7.  The most sensitive diagnostic modality of choice is MRI with MR
venography.
8. Multiple risk factors can be present in a single patient.
9. Anticoagulants is appropriate and the prognosis is generally
favorable.
10. Systematic workup of hereditary thrombophilic conditions can be
done wherever possible to find out the treatable cause.
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ANNEXURE
v Proforma
v Master Chart
v Ethical Committee
Approval Order
v Consent Form
                                              PROFORMA
NAME:                                                    DOA:
AGE:                                                        DOD/E:
SEX: male / female                                   Hospital No:
Occupation:                                               Address:
Socio-economic status:                              Literacy status:
COMPLAINTS:
1. Head ache: yes/no                        a) Type: frontal/temporal/occipital/diffuse
                                                         b) Side: right/left/bilateral
                                                         c) Duration:
 2. Convulsions:  yes/no                  a) focal/GTCS/focal +GTCSFOCAL
                                                        b) single/status/multiple
                                                        c) Duration:
 3. Limb weakness:  yes/no             right/left/both
4. Consciousness:  normal/altered
5. Speech disturbances: normal/aphasic
6. Visual disturbances: yes/ no
7. Chronoloogy of symptoms: static/progressive/regressive/fluctuating
8. Neuro psychiatric illness:
9. Non-neurologic symptoms:                                              yes/no
     Fever
     Vomiting
     Diarrhea
     Ear ache/ discharge
10. Rheumatological symptoms:                                        yes/no
    Arthralgia
   Oral ulcers
   Skin rashes
   Alopecia
   Photosensitivity
   Others
PAST HISTORY:
    DM/SHT/TB/CAD/OCP intake/similar illness/epileptic
PERSONAL HISTORY:
    1. Smoker   yes/no                      2. Alcohol   yes/no
    3. I.V drug abuse   yes/no          4. Pan user yes/no
MENSTRUAL HISTORY: (If female)
   Regularity:                          Married: yes/no             Abortions:
IF POSTPARTUM:
 a. Duration of pregnancy at delivery
  Abortion/Pre term/Full term/Post term
 b. Place of delivery: Home / Hospital
 c. Type of delivery: Normal / Caesarean
 d. Antecedent events: Present / Absent
  If present, Pre-eclampsia/APH/PPH/Retained placenta
 e. Duration between delivery and onset of symptoms
  < 24 hr/1-10 days/11-20 days/20-30 days/>30 days.
FAMILY HISTORY: DM/ SHT/ stroke/ rheumatologic illness.
CLINICAL FINDINGS:
   Pulse                             BP                             temp
   Pallor: Present / Absent
   Icterus: Present / Absent
   Cyanosis: Present / Absent
   Clubbing: Present / Absent
   Pedal edema: Present / Absent
   Lymphadenopathy : Present/Absent
   Signs of dehydration:
SYSTEMIC EXAMINATION:
Neurological Examination:
1. Glasgow Coma Scale
  2. Level of consciousness: Conscious/Drowsy/Stuporus/Coma
  3. Speech: Normal/Aphasia
  4. Fundi abnormalities: RT                      LT                        (Normal/ Papilledema)
  5. Gaze paresis
  6. Cranial nerve palsies
  7. Tone:              RT                      LT                        (Normal/Increased/ Decreased)
                   UL
                   LL
8. Power:              RT                      LT                        (Normal/ Decreased)
                   UL
                   LL
9. Deep tendon reflexes:              RT                      LT       (Normal/Brisk/Sluggish)
   UL
                                          LL
10. Plantar reflex:        RT               LT             (Flexor/Extensor/Equivocal)
11. Sensory system:     RT               LT            (Normal/Decreased/Cannot be assessed)
12. Cerebellar system: RT               LT             (Present/Absent/Cannot be tested)
13. Extra pyramidal involvement:  Present / Absent
13. Gait abnormalities: Present / Absent
14. Bladder involvement: Present / Absent
15. Signs of meningeal irritation: Present / Absent
  CVS: Normal/Abnormal
RS: Normal/Abnormal
   P/A:  Normal/Abnormal
  ENT: 1. Sinusitis    -   Present / Absent           2.Mastoiditis - Present / Absent
INVESTIGATIONS
Hb:     TC:    DC:    N    L   M   E   B    ESR:                    Platelets:
P/S:
BT:          CT:            PT:            INR:                   APTT:
RBS:
T.Cholesterol:
LDL:
TGL:
Serum urea:
Serum creatinine:
Serum sodium:
Serum potassium:
Serum bilirubin:
ECG:
Urine routine:
Chest X-ray PA view:
CT:
MRV:
ANA (if done):
APLA (if done):
RA factor (if done)
TREATMENT DETAILS:
Anti coagulants:
             Anti edema measures:
             Anti epileptics:
             Physiotherapy:
OUTCOME:
Improved/ Static/ Deteriorated/Expired.

PATIENT CONSENT FORM
Title :     Anemia in post renal transplant patients
Study centre                     :     Govt.general hospital, MMC,chennai
Patient’s name :
Patient’s age :
Identification number :
 I confirm that I have understood the purpose of the procedures
of   the above study. I have had the opportunity to ask questions and all
my questions have been answered satisfactorily.
           I understand that my participation in the study is entirely
voluntary and that I am free to withdraw from the study at any time
without my legal rights being affected
I understand that sponsors of the study, others working on
sponsor’s behalf, the ethics committee and the regulatory
authorities
will not need my permission to look at my health records both in
respect of current study and any future research that may be conducted
in relation to it; even if I withdraw from the study I agree to this
access. However I understand that my identity will not be
revealed in any information released to third parties unless
required by law. I agree not to restrict the use of any data or
results arising from the study.
I agree to take part in the above the study an to comply with
the instructions given during the study and inform about any change in
my health status to the investigator.
I hereby give permission to undergo complete clinical
examination and investigations as part of the study.
Signature of the patient
Patient’s name and address place
date
Signature of the investigator
Investigator’s name
place
date
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1. AMUDHA 22 F SA P + - - D + - - PIH - +++ S - 9,10 + PE - A
2. JOTHI RAMAN 29 M SA NP + + FO/GT CO - - - INS S/A - US LH - + PE - D
3. SWATHY 25 F SA P + - GT S + - - SEI - + S - - - - - A
4. BABU 21 M A NP + + GT C - - - - A - S LH - - DB - A
5. PRABHU 31 M SA NP + + GT S + - - HT S/A - US RH 6 + PE - A
6. KARTHIKEYAN 28 M CH NP + - - C + - - HIV PAN - S - - N - D
7. SATHYA 34 M SA NP + + FO/GT D - - - - S/A - S LH - + DB 11 A
8. RAJESHVARI 55 F A NP - + - C - - + HT/DM - + S RH - - - - A
9. CHANDRAN 40 M SA NP + + GT D - - - - S/A - S LH 3 - - - A
10. GURU 27 M A NP + - - C + - - TB S/A - S - 6 + PE RALES A
11. NATHAN 32 M SA NP - + FO/GT S + + - CSOM - ++ S RH 8 - - CSOM A
12. SANGEETHA 20 F A P + - GT S - - - - - + S - 6 + PE - A
13.PRAKASH 28 M SA NP + + SE CO - - - BA S/A - US FB 6 + PE WHEEZ D
14.MOHAN 42 M SA NP + + GT D - - - HT S - S LH - - - - A
15. ABRAHAM 40 M A NP + + FO/GT D + - - - S/A - US RH 6 + PE - D
16. KUMAR 36 M SA NP + - GT S + - - - - + US - - + DB - A
17. AMULU 23 F SA P + - SE CO - - - - - ++ US - 7 - - - D
18. CHITHRA 26 F A P + - GT D - - - - - ++ S - - - - - A
19. MURUGAN 31 M CH NP + + FO C - - - APLA PAN + RH - - DB - A
20. PONNI 25 F SA P + - FO C + - - RHD - + - - - DB MDM A
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21.MANOJ 20 M SA NP - - - C - - - - PAN - - - - - - A
22.SHANTHI 22 F SA P + + GT D + - - - - ++ RH - + DB - A
23.KAVITHA 21 F A P + - FO/GT S + - - - - ++ - - - DB - A
24.MURUGAN 27 M SA NP + + GT D - - - TB S - LH 7,9,10 - - RALES A
25. STALIN 32 M SA NP + FO C - - - - S/A - LH - - - - A
26. VASANTHA 43 F CH NP - - SE S + - - DM - - - 6 + PE - A
27. MANJU 27 F SA P + + GT D + - - - PAN - LH 7 - - - A
28. SABARI 26 M A NP + + - C - - - - - - RH - - - - A
29. VASU 33 M SA NP + + GT CO + - - HIV PAN - RH - + DB - D
30. BAVANI 25 F A P + - - C - - - - - + - - - - - A
31.NAMADEVAN 30 M SA NP + + FO C - - - - S - LH - - DB - A
32.SAROJA 24 F A P + - FO/GT CO - - - PIH - + - - - - - D
33. KRISHNAMURTHI38 M SA NP + + GT D - - - - S/A - FB - - - - A
34. SHAH 41 M SA NP + + FO/GT D + - - HT S - RH 3 + DB - A
35. BALAN 36 M A NP + + GT D + - - BA S/A - LH - - - WHEEZ A
36. VADIVU 26 F SA P + - FO C - - - - - ++ - - - - - A
37. YASODA 29 F SA P + - GT CO + - - - - + - - - DB - D
38. MURUGAMMAL 22 F A P + - - C - - - - - + - - - - - A
39.SIVARAMAN 36 M SA NP + + FO/GT S + - - CSOM PAN - LH 8 + DB CSOM A
40. PITCHAI 29 M SA NP + - FO C - - - - S/A - - - - - - A
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1. AMUDHA 94 84 2.1 N 4 2.2 N N NHI + + + + + 1.37 N N A
2. JOTHI RAMAN 110 24 0.7 N 12 3.2 - EDS HI + + + 0.9 HI N D
3. SWATHY 100 32 0.8 N 8.2 3.1 P N N + 0.92 N ACL A
4. BABU 98 35 0.9 N 17.2 2.6 - CS E + + 1.13 N N A
5. PRABHU 112 33 0.8 N 14 3.5 N HI + 1.21 N - A
6. KARTHIKEYAN 84 34 0.8 N 12 3.1 N DTS BHI + 1.12 HI - D
7. SATHYA 111 28 0.7 N 13 2.3 - HI + 1.27 HI - A
8. RAJESHVARI 234 110 3.2 N 9 2.4 - NHI + 1.27 N - A
9. CHANDRAN 96 42 1.1 N 12 2.6 - MS/ME + + + + 1.15 HI - A
10. GURU 99 32 1 N 13 2.8 p/c/x EDS HI + 1.18 N - A
11. NATHAN 103 28 0.8 N 7.8 2.4 C HI/E + + + 1.15 HI - A
12. SANGEETHA 102 26 0.7 N 8 2.8 - HI + 1.13 N - A
13.PRAKASH 121 82 1.8 N 15 3.6 - ME/E + 1.21 HI - D
14.MOHAN 109 30 0.8 N 13 3.1 - HI + 1.12 N - A
15. ABRAHAM 106 28 0.7 N 14 2.6 C MS/E + 1.27 HI - D
16. KUMAR 98 26 0.7 N 10 3.4 N HI + 1.27 N N A
17. AMULU 120 32 0.9 N 7.2 2.9 - ME/NS + 1.37 N N D
18. CHITHRA 131 36 1 N 7.6 3.4 - N N + 0.9 N - A
19. MURUGAN 85 40 1.2 N 8.4 2.4 - HI + 1.22 N ACL A
20. PONNI 76 44 1.1 N 9.6 3.1 N HI 1.11 N N A
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21.MANOJ 75 38 1 N 14 3.8 - HI + 1.22 HI A
22.SHANTHI 96 42 1.1 N 7.2 3.5 N CS HI + 1.1 N - A
23.KAVITHA 113 36 0.9 N 7.1 3.6 - BHI/E + + 1.3 N - A
24.MURUGAN 112 36 0.8 N 12 2.6 P/C/X HI + 0.9 HI - A
25. STALIN 86 28 0.7 N 14 3.8 - CS HI + 1.25 HI - A
26. VASANTHA 116 44 1.1 N 13 3.1 C HI + 1.1 N - A
27. MANJU 110 38 0.9 N 12 2.9 C HI + 1.21 N - A
28. SABARI 87 36 0.8 N 13 3.4 - HI + 1.1 N - A
29. VASU 99 48 1.2 N 13 1.9 N ME/E + 0.9 HI - D
30. BAVANI 82 42 1.1 N 9.4 1.9 - EDS HI + 0.9 N N A
31.NAMADEVAN 93 40 1 N 13 3.2 - HI + 1.13 N - A
32.SAROJA 81 96 2.8 N 9.8 2.3 - MS/E + + 1.21 HI - D
33. KRISHNAMURTHI 79 26 0.7 N 14 2.7 - NHI + + 1.12 HI - A
34. SHAH 115 46 1.2 N 13 2.4 P N N + 1.27 HI - A
35. BALAN 114 36 0.8 N 12 2.9 P HI + 1.27 N - A
36. VADIVU 73 28 0.7 N 7.8 2.6 - HI + 1.15 N N A
37. YASODA 74 40 0.9 N 9.2 3.5 N CS ME/MS + 1.18 HI - D
38. MURUGAMMAL 82 72 1.7 N 9.4 2.6 - HI + 1.15 N - A
39.SIVARAMAN 118 28 0.7 N 12 3.1 P BHI/E + + + 1.1 HI C/S A
40. PITCHAI 86 36 0.9 N 14 3.4 - HI + 0.9 HI - A
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